Epsilon Molecular Engineering is a biotechnology company focuses on biomolecule and aptamer development for therapeutic applications.
Epsilon Molecular Engineering's investors include Saitama Shibusawa MIX Innovation Creation Support Fund, Mitsubishi UFJ Capital, UntroD Capital, Japan Finance Corporation, Shoko Chukin Bank.
Epsilon Molecular Engineering is headquartered in Saitama, Japan.
Epsilon Molecular Engineering is a biotechnology company focuses on biomolecule and aptamer development for therapeutic applications.
Epsilon Molecular Engineering is at the Debt Financing stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Epsilon Molecular Engineering — Funding & Investors." VCBacked, May 28, 2026, https://www.vcbacked.co/company/epsilon-molecular-engineering. Accessed September 29, 2026.
VCBacked. (2026). Epsilon Molecular Engineering — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/epsilon-molecular-engineering
{{cite web |title=Epsilon Molecular Engineering — Funding & Investors |url=https://www.vcbacked.co/company/epsilon-molecular-engineering |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated